Phase change material Market Research Report Forecast till 2028

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 15 1.1 MARKET ATTRACTIVENESS ANALYSIS 17 1.1.1 GLOBAL PHASE CHANGE MATERIALS MARKET, BY TYPE 18 1.1.2 GLOBAL PHASE CHANGE MATERIALS MARKET, BY EQUIPMENT 19 1.1.3 GLOBAL PHASE CHANGE MATERIALS MARKET, BY TEMPERATURE RANGE 20 1.1.4 GLOBAL PHASE CHANGE MATERIALS MARKET, BY END-USER 21 1.1.5 GLOBAL PHASE CHANGE MATERIALS MARKET, BY REGION 22 2 MARKET INTRODUCTION 23 2.1 DEFINITION 23 2.2 SCOPE OF THE STUDY 23 2.3 MARKET STRUCTURE 23 3 RESEARCH METHODOLOGY 24 3.1 RESEARCH PROCESS 24 3.2 PRIMARY RESEARCH 25 3.3 SECONDARY RESEARCH 26 3.4 MARKET SIZE ESTIMATION 26 3.5 TOP-DOWN AND BOTTOM-UP APPROACH 27 3.6 FORECAST MODEL 28 3.7 LIST OF ASSUMPTIONS & LIMITATIONS 29 4 MARKET DYNAMICS 30 4.1 INTRODUCTION 30 4.2 DRIVERS 31 4.2.1 GROWING DEMAND FOR PCMS IN DRUG DELIVERY AND VACCINE AND MEDICINAL TRANSPORT 31 4.2.2 USE OF PCMS FOR THERAPEUTIC HYPOTHERMIA IN NEONATAL AND RHEUMATIC DISEASES 32 4.3 RESTRAINTS 33 4.3.1 DISADVANTAGES ASSOCIATED WITH PCM PRODUCTS 33 4.4 OPPORTUNITIES 34 4.4.1 INCREASING NUMBER OF CLINICAL TRIALS AND DEVELOPMENT OF NEW THERAPIES 34 4.5 CHALLENGES 35 4.5.1 REGULATIONS IN THE COLD SUPPLY CHAIN 35 5 MARKET FACTOR ANALYSIS 36 5.1 SUPPLY CHAIN ANALYSIS 36 5.1.1 RAW MATERIAL SUPPLIERS 37 5.1.1.1 INORGANIC 37 5.1.1.2 ORGANIC 37 5.1.1.3 EUTECTIC 38 5.1.2 PHASE CHANGE MATERIALS PRODUCERS 38 5.1.3 DISTRIBUTION & SALES CHANNEL 38 5.1.4 END-USER 39 5.2 PORTER'S FIVE FORCES ANALYSIS 39 5.2.1 THREAT OF NEW ENTRANTS 40 5.2.2 BARGAINING POWER OF SUPPLIERS 40 5.2.3 THREAT OF SUBSTITUTES 40 5.2.4 BARGAINING POWER OF BUYERS 40 5.2.5 INTENSITY OF RIVALRY 40 5.3 IMPACT OF COVID 19 OUTBREAK ON GLOBAL PHASE CHANGE MATERIALS MARKET 40 5.3.1 IMPACT ON GLOBAL ECONOMY 40 5.3.2 IMPACT ON SUPPLY CHAIN OF PHASE CHANGE MATERIALS MARKET 41 5.3.3 MAJOR GOVERNMENT POLICIES TO COUNTER THE IMPACT OF COVID-19 42 5.3.3.1 MONETARY AND MACRO-FINANCIAL 46 5.3.4 QUALITATIVE ANALYSIS ON CHANGES IN DEMAND FROM END-USERS 47 5.3.4.1 BIOPHARMACEUTICAL COMPANIES 47 5.3.4.2 HOSPITALS 47 5.3.4.3 MEDICAL LABORATORIES 47 6 GLOBAL PHASE CHANGE MATERIALS MARKET, BY TYPE 48 6.1 INTRODUCTION 48 6.2 ORGANIC 49 6.3 INORGANIC 50 6.4 EUTECTIC 51 7 GLOBAL PHASE CHANGE MATERIALS MARKET, BY EQUIPMENT 52 7.1 INTRODUCTION 52 7.2 REFRIGERATORS 53 7.3 COLD BOXES 54 7.4 CARRIERS 55 8 GLOBAL PHASE CHANGE MATERIALS MARKET, BY TEMPERATURE RANGE 56 8.1 INTRODUCTION 56 8.2 -20 TO -35 DEG C 57 8.3 2 TO 8 DEG C 58 8.4 10 TO 15 DEG C 59 8.5 OTHERS 60 9 GLOBAL PHASE CHANGE MATERIALS MARKET, BY END-USER 61 9.1 INTRODUCTION 61 9.2 BIOPHARMACEUTICAL COMPANIES 62 9.3 HOSPITALS 63 9.4 MEDICAL LABORATORIES 64 9.5 OTHERS 65 10 GLOBAL PHASE CHANGE MATERIALS MARKET, BY REGION 66 10.1 INTRODUCTION 66 10.2 NORTH AMERICA 68 10.2.1 US 71 10.2.2 CANADA 73 10.3 EUROPE 75 10.3.1 GERMANY 78 10.3.2 UK 80 10.3.3 FRANCE 82 10.3.4 SPAIN 84 10.3.5 ITALY 86 10.3.6 REST OF EUROPE 88 10.4 ASIA-PACIFIC 90 10.4.1 CHINA 93 10.4.2 INDIA 95 10.4.3 JAPAN 97 10.4.4 SOUTH KOREA 99 10.4.5 REST OF ASIA-PACIFIC 101 10.5 LATIN AMERICA 103 10.5.1 BRAZIL 106 10.5.2 MEXICO 108 10.5.3 ARGENTINA 110 10.5.4 REST OF LATIN AMERICA 112 10.6 MIDDLE EAST & AFRICA 114 10.6.1 GCC COUNTRIES 117 10.6.2 SOUTH AFRICA 119 10.6.3 REST OF THE MIDDLE EAST & AFRICA 121 11 COMPETITIVE LANDSCAPE 123 11.1 INTRODUCTION 123 11.2 MARKET STRATEGY ANALYSIS 123 11.3 COMPETITIVE BENCHMARKING 124 12 COMPANY PROFILES 125 12.1 CRODA INTERNATIONAL PLC 125 12.1.1 COMPANY OVERVIEW 125 12.1.2 FINANCIAL OVERVIEW 126 12.1.3 PRODUCTS OFFERED 126 12.1.4 KEY DEVELOPMENTS 127 12.1.5 SWOT ANALYSIS 127 12.1.6 KEY STRATEGIES 127 12.2 SASOL 128 12.2.1 COMPANY OVERVIEW 128 12.2.2 FINANCIAL OVERVIEW 128 12.2.3 PRODUCTS OFFERED 129 12.2.4 KEY DEVELOPMENTS 129 12.2.5 SWOT ANALYSIS 129 12.2.6 KEY STRATEGIES 130 12.3 HENKEL AG & CO. KGAA 131 12.3.1 COMPANY OVERVIEW 131 12.3.2 FINANCIAL OVERVIEW 131 12.3.3 PRODUCTS OFFERED 132 12.3.4 KEY DEVELOPMENTS 132 12.3.5 SWOT ANALYSIS 132 12.3.6 KEY STRATEGIES 133 12.4 CRYOPAK 134 12.4.1 COMPANY OVERVIEW 134 12.4.2 FINANCIAL OVERVIEW 134 12.4.3 PRODUCTS OFFERED 134 12.4.4 KEY DEVELOPMENTS 134 12.4.5 SWOT ANALYSIS 135 12.4.6 KEY STRATEGIES 135 12.5 MERCK KGAA 136 12.5.1 COMPANY OVERVIEW 136 12.5.2 FINANCIAL OVERVIEW 137 12.5.3 PRODUCTS OFFERED 137 12.5.4 KEY DEVELOPMENTS 138 12.5.5 SWOT ANALYSIS 138 12.5.6 KEY STRATEGIES 138 12.6 PLUSS ADVANCED TECHNOLOGIES PVT. LTD 139 12.6.1 COMPANY OVERVIEW 139 12.6.2 FINANCIAL OVERVIEW 139 12.6.3 PRODUCTS OFFERED 139 12.6.4 KEY DEVELOPMENTS 140 12.6.5 SWOT ANALYSIS 141 12.6.6 KEY STRATEGIES 141 12.7 PURETEMP 142 12.7.1 COMPANY OVERVIEW 142 12.7.2 FINANCIAL OVERVIEW 142 12.7.3 PRODUCTS OFFERED 142 12.7.4 KEY DEVELOPMENTS 142 12.7.5 SWOT ANALYSIS 143 12.7.6 KEY STRATEGIES 143 12.8 TEAPPCM 144 12.8.1 COMPANY OVERVIEW 144 12.8.2 FINANCIAL OVERVIEW 144 12.8.3 PRODUCTS OFFERED 144 12.8.4 KEY DEVELOPMENTS 144 12.8.5 SWOT ANALYSIS 145 12.8.6 KEY STRATEGIES 145 12.9 RUBITHERM 146 12.9.1 COMPANY OVERVIEW 146 12.9.2 FINANCIAL OVERVIEW 146 12.9.3 PRODUCT OFFERINGS 146 12.9.4 KEY DEVELOPMENTS 147 12.9.5 SWOT ANALYSIS 147 12.9.6 KEY STRATEGIES 147 12.10 PCM PRODUCTS LTD 148 12.10.1 COMPANY OVERVIEW 148 12.10.2 FINANCIAL OVERVIEW 148 12.10.3 PRODUCT OFFERINGS 148 12.10.4 KEY DEVELOPMENTS 149 12.10.5 SWOT ANALYSIS 149 12.10.6 KEY STRATEGIES 149 12.11 COLD CHAIN TECHNOLOGIE 150 12.11.1 COMPANY OVERVIEW 150 12.11.2 FINANCIAL OVERVIEW 150 12.11.3 PRODUCT OFFERINGS 150 12.11.4 KEY DEVELOPMENTS 151 12.11.5 SWOT ANALYSIS 151 12.11.6 KEY STRATEGIES 151 13 APPENDIX 152 13.1 REFERENCES 152 13.2 RELATED REPORTS 153